Skip to content

US · TRNS · INDUSTRIAL - DISTRIBUTION

Transcat, Inc. (TRNS) intrinsic value and stock valuation

$92.97as of 2026-11-21 · Mkt cap 871.49M

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Transcat, Inc. DCF and intrinsic value

InvestorsCraft values TRNS with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from TRNS’s statements →

Transcat, Inc. Graham Number

Graham Number: $20.44d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Industrials · Industrial - Distribution Rochester, NY 14624 transcat.com

How the business is doing

Fiscal 2012–2026, USD

Revenue
$331.9M+13.9% 5y CAGRd
20122026
Net income
$5.38M-7.1% 5y CAGRd
20122026
Free cash flow
$19.6M+2.8% 5y CAGRd
20122026
Total equity
$300.6M+32% 5y CAGRd
20122026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2012–2026, USD
20262025202420232022
Revenue$331.9M$278.4M$259.5M$230.6M$205M
Operating income$13.3M$17.9M$19.8M$16.3M$14.1M
Net income$5.38M$14.5M$13.7M$10.7M$11.4M
EPSd$576.6K$1.57M$1.63M$1.4M$1.5M
Operating cash flow$34.9M$39M$32.6M$17M$17.6M
Capital expenditure-$-15.3M-$-13.2M-$-13.28M-$-9.41M-$-10.15M
Free cash flow$19.6M$25.8M$19.3M$7.54M$7.47M
Total assets$480.5M$385.2M$287.6M$195.8M$177.8M
Total debt$128.9M$57.7M$21.5M$64.4M$57.7M
Net debt$123.9M$56.2M$1.89M$62.9M$56.3M
Total equity$300.6M$286.9M$225.2M$99.6M$86.2M
Cash and short-term investments$4.94M$1.52M$35.2M$1.53M$1.4M
Income statement
20262025202420232022
Revenue$331.9M$278.4M$259.5M$230.6M$205M
Cost of revenue$223.6M$189M$175.7M$162.2M$146.5M
Gross profit$108.3M$89.5M$83.8M$68.4M$58.4M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$95M$71.6M$64M$52.1M$44.3M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$95M$71.6M$64M$52.1M$44.3M
Cost and expenses$318.6M$260.6M$239.7M$214.3M$190.8M
Interest income$0.00$820K$810K$0.00$0.00
Interest expense$5.27M$800K$1.83M$2.42M$810K
Depreciation and amortization$26.2M$18.6M$13.5M$11M$9.57M
Ebitda$38.8M$37.7M$33.8M$26.9M$23.6M
Operating income$13.3M$17.9M$19.8M$16.3M$14.1M
Total other income/expenses, net-$-5.27M$450K-$-1.34M-$-2.76M-$-950K
Income before tax$7.99M$18.3M$18.4M$13.5M$13.2M
Income tax expense$2.61M$3.81M$4.79M$2.8M$1.81M
Net income$5.38M$14.5M$13.7M$10.7M$11.4M
Weighted average shares outstanding$9.33M$9.19M$8.24M$7.55M$7.5M
Weighted average diluted shares outstanding$9.33M$9.25M$8.35M$7.64M$7.59M
Balance sheet
20262025202420232022
Cash and short-term investments$4.94M$1.52M$35.2M$1.53M$1.4M
Net receivables$65.8M$56.3M$48.3M$45.2M$40.3M
Inventory$13.7M$14.5M$17.4M$16.9M$12.7M
Total current assets$92.5M$78M$105.2M$67.6M$59.7M
Property, plant and equipment, net$57.8M$74.4M$55.8M$43.9M$37.5M
Goodwill and intangible assets$295.9M$231.7M$125.6M$83.2M$79.8M
Long-term investments$0.00$100K$0.00$0.00$0.00
Total non-current assets$388M$307.2M$182.4M$128.2M$118.1M
Total assets$480.5M$385.2M$287.6M$195.8M$177.8M
Accounts payable$17.9M$16.8M$11.5M$15.9M$14.2M
Short-term debt$0.00$5.44M$4.85M$4.58M$2.16M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$39.6M$34M$33.5M$28.3M$27.7M
Long-term debt$128.9M$52.3M$16.7M$59.8M$55.5M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$140.2M$64.3M$28.9M$67.8M$63.9M
Capital lease obligations$29M$25M$17.4M$15.3M$9.19M
Total liabilities$179.9M$98.4M$62.4M$96.1M$91.6M
Common stock$4.67M$4.66M$4.42M$3.78M$3.77M
Retained earnings$97.8M$92.5M$80.1M$69.2M$58.7M
Accumulated other comprehensive income (loss)-$-920K-$-1.47M-$-950K-$-1.2M-$-230K
Total equity$300.6M$286.9M$225.2M$99.6M$86.2M
Total investments$0.00$100K$15.5M$0.00$0.00
Total debt$128.9M$57.7M$21.5M$64.4M$57.7M
Net debt$123.9M$56.2M$1.89M$62.9M$56.3M
Cash flow statement
20262025202420232022
Net income$5.38M$14.5M$13.7M$10.7M$11.4M
Depreciation and amortization$26.2M$18.6M$13.5M$11M$9.57M
Stock-based compensation$7.55M$3.25M$4.51M$3.38M$2.33M
Change in working capital-$-11.9M$3.21M$2.05M-$-8.04M-$-6.34M
Accounts receivable-$-6.58M-$-1.29M$410K$70K-$-3.39M
Inventory$840K$4.39M$2.32M-$-3.38M-$-120K
Accounts payable$960K$4.94M-$-5M$1.6M$1.9M
Net cash provided by operating activities$34.9M$39M$32.6M$17M$17.6M
Investments in property, plant and equipment-$-15.3M-$-13.2M-$-13.28M-$-9.41M-$-10.15M
Acquisitions, net-$-82.53M-$-87.44M-$-12.86M-$-9.11M-$-29.81M
Net cash used for investing activities-$-97.82M-$-84M-$-41.67M-$-18.51M-$-39.85M
Common stock issued$840K$1.87M$77.3M$660K$1.49M
Common stock repurchased-$-470K-$-3.56M-$-4.91M-$-450K-$-6.68M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$66.5M$26.9M$27.4M$880K$23.7M
Net change in cash$3.42M-$-18.13M$18.1M$140K$840K
Cash at end of period$4.94M$1.52M$19.7M$1.53M$1.4M
Operating cash flow$34.9M$39M$32.6M$17M$17.6M
Capital expenditure-$-15.3M-$-13.2M-$-13.28M-$-9.41M-$-10.15M
Free cash flow$19.6M$25.8M$19.3M$7.54M$7.47M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Transcat, Inc.

        Transcat, Inc. offers comprehensive calibration and instrument services for laboratories, serving clients across the United States, Canada, and other international markets. The company operates through two distinct divisions: Service and Distribution. The Service division delivers a wide array of offerings, including precision calibration, equipment repair, thorough inspections, analytical qualification, preventive maintenance, and expert consulting. This segment also features its proprietary software, CalTrak, designed to manage documents and assets while streamlining the operational workflow for its calibration centers and customer equipment. Additionally, its "Compliance, Control and Cost" online portal grants customers web-based asset management capabilities and a secure, off-site repository for calibration and other service records. The Distribution division focuses on the sale and rental of instruments for testing, measurement, and control purposes. It also provides valuable supplementary services such as the calibration and certification of newly purchased equipment, equipment leasing, sales of pre-owned machinery, and customized equipment kitting. This division engages customers through its online platform, various digital and print marketing campaigns, proactive outbound sales efforts, and an incoming call center. Transcat primarily caters to highly regulated sectors, particularly the life sciences—encompassing pharmaceutical, biotechnology, medical device, and other FDA-regulated entities. Furthermore, it extends its services and products to aerospace and defense, industrial manufacturing, energy, utilities, and other industries where process accuracy and confirmed equipment performance are paramount. Established in 1964, Transcat, Inc. maintains its corporate headquarters in Rochester, New York.

        CEO
        Jaime A. Irick
        Employees
        1.41K
        Beta
        0.68

        Explore

        Frequently asked questions

        What is the intrinsic value of Transcat, Inc. (TRNS)?

        Transcat, Inc. (TRNS) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is TRNS undervalued?

        TRNS trades at a price of $92.97 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.